885
Views
33
CrossRef citations to date
0
Altmetric
Articles

Polymer-drug conjugates as nanomedicine: a review

, & ORCID Icon
Pages 990-1014 | Received 28 Mar 2019, Accepted 11 Aug 2019, Published online: 19 Sep 2019
 

Abstract

The majority of anti-cancer drugs show poor water solubility and produce adverse effects in healthy tissue. The combination of polymer technology and targeted drug delivery system may overlay the way for more effective yet safer therapeutic options for cancer therapy. Polymer drug conjugate are the polymer based prodrugs designed to increase the aqueous solubility of anti-cancers drugs, subsequently enhance the bioavailability. This update introduced basic concept of polymer drug conjugates (PDC) (prodrug) and provided an overview on currently used synthetic strategies for PDCs. In addition, brief overview on various polymer-drug conjugates updating their clinical status and highlights with major anticipated clinical application in cancer therapy.

GRAPHICAL ABSTRACT

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,070.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.